CNRMF (China Regenerative Medicine International) 9-Day RSI: N/A (As of Aug. 08, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CNRMF China Regenerative Medicine International Ltd CNRMF
30 GF Score
Price $0.04
GF Value $0.09
! 5 Warning Signs
View Full Analysis

What is China Regenerative Medicine International 9-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.

As of today (2026-08-08), China Regenerative Medicine International's 9-Day RSI is N/A.

The industry rank for China Regenerative Medicine International's 9-Day RSI or its related term are showing as below:

CNRMF's 9-Day RSI is not ranked *
in the Biotechnology industry.
Industry Median: 51.055
* Ranked among companies with meaningful 9-Day RSI only.

China Regenerative Medicine International  (OTCPK:CNRMF) 9-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.


China Regenerative Medicine International 9-Day RSI Related Terms


CNRMF vs VRTX, REGN, RVMD: 9-Day RSI Comparison

For the Biotechnology subindustry, China Regenerative Medicine International's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Regenerative Medicine International 9-Day RSI vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, China Regenerative Medicine International's 9-Day RSI distribution charts can be found below:

* The bar in red indicates where China Regenerative Medicine International's 9-Day RSI falls into.


CNRMF
30GF Score
China Regenerative Medicine International Ltd CNRMF
9-Day RSI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

China Regenerative Medicine International  (OTCPK:CNRMF) 9-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is China Regenerative Medicine International (CNRMF) Overvalued in 2026?

Based on GuruFocus' analysis, China Regenerative Medicine International stock appears to be undervalued. The current stock price of $0.04 is trading 61.1% below its estimated GF Value™ of $0.09.

Key valuation signals for CNRMF:

  • 9-Day RSI: N/A
  • GF Value™: $0.09 vs. price of $0.04 (61.1% below fair value)
  • GF Score™: 30/100 with 5 warning signs

No single metric tells the full story. See the CNRMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


China Regenerative Medicine International Business Description

Other Exchanges 08158:Hong Kong
Address 132 Nathan Road, Suite 2310-2318, Miramar Tower, Tsim Sha Tsui, Kowloon, HKG
China Regenerative Medicine International Ltd is an investment holding company. The company is engaged in the provision of healthcare products and services. It is engaged in research and development, production and sales of tissue engineering and regenerative medicine products. The business scope of company includes tissue engineering, cosmetics, cell storage, preparation and therapy, hospitals administration and other business division. The segments of the company are Aesthetic medical and beauty services and Medical services. The majority of the company's revenue is derived from its Aesthetic medical and beauty services segment that provides medical beauty products and services. Geographically, the Hong Kong accounts for the majority of the revenue and also has a presence in PRC.
30GF Score

Get the complete analysis for CNRMF

9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.04
Price
$0.09
GF Value